Alicia Zhou, Chief Executive Officer of the Cancer Research Institute, shared a post on LinkedIn by CRI, adding:
“I am honored and humbled to be recognized by OncoDaily as one of the 100 Most Influential CEOs in Oncology in 2025 – and what an amazing list to be included on!
I truly love this job. Being able to make an impact for scientists, researchers, and patients alike is an absolute privilege – especially during these pivotal times. Just in the past year at the Cancer Research Institute (CRI), we have been able to launch our critical career-transition funding initiative: IGNITE, we’ve doubled down on our investment in trainees through our Irvington Postdoctoral Fellowships, and we’ve launched our AI-ready data initiative: the CRI Discovery Engine.
2025 was indeed a busy year – and 2026 promises to be full of even more insights, innovation, and impact!”
Quoting Cancer Research Institute’s post:
“CRI is proud to announce that Alicia Zhou, PhD, has been named one of the 100 Most Influential CEOs in Oncology in 2025 by OncoDaily!
‘This list recognizes 100 Chief Executive Officers whose leadership has had a measurable and lasting impact on the global oncology ecosystem. Together, they influence the full continuum of cancer care: from discovery and clinical development to access, education, survivorship, and end-of-life care,’ OncoDaily describes.
Discover how our CEO is making a meaningful impact during a pivotal moment in the field.”
